Cosmos Health (COSM) Stock Price, News & Analysis

Company Overview

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors. It sells its products through independent wholesale distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.

Key Stats

• Today's Range: $0.61 to $0.68
• 50-Day Range: $0.39 to $1.15
• 52-Week Range: $0.28 to $1.28
• Volume: 236,403 shs
• Average Volume: 496,458 shs
• Market Capitalization: $19.61 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Cosmos Health Stock Analysis - MarketRank™

Cosmos Health scored higher than 25% of companies evaluated by MarketBeat, and ranked 841st out of 932 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Cosmos Health.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Cosmos Health are expected to grow in the coming year, from ($0.78) to $0.01 per share.

Price to Book Value per Share Ratio

Cosmos Health has a P/B Ratio of 0.62. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.27% of the float of Cosmos Health has been sold short.

Short Interest Ratio / Days to Cover

Cosmos Health has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Cosmos Health has recently decreased by 6.55%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Cosmos Health does not currently pay a dividend.

Dividend Growth

Cosmos Health does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

3.27% of the float of Cosmos Health has been sold short.

Short Interest Ratio / Days to Cover

Cosmos Health has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Cosmos Health has recently decreased by 6.55%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

Search Interest

Only 2 people have searched for COSM on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

MarketBeat Follows

3 people have added Cosmos Health to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Cosmos Health insiders have not sold or bought any company stock.

Percentage Held by Insiders

25.10% of the stock of Cosmos Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 12.61% of the stock of Cosmos Health is held by institutions.

COSM Stock Analysis - Frequently Asked Questions

How have COSM shares performed this year?

Cosmos Health's stock was trading at $0.6690 on January 1st, 2025. Since then, COSM stock has decreased by 3.0% and is now trading at $0.6490.

How were Cosmos Health's earnings last quarter?

Cosmos Health Inc. (NASDAQ:COSM) released its quarterly earnings results on Monday, August, 18th. The company reported ($0.06) EPS for the quarter, missing the consensus estimate of $0.01 by $0.07. The business earned $14.75 million during the quarter, compared to analyst estimates of $17.48 million. Cosmos Health had a negative net margin of 27.90% and a negative trailing twelve-month return on equity of 18.32%.

When did Cosmos Health's stock split?

Cosmos Health's stock reverse split on Thursday, December 15th 2022.The 1-25 reverse split was announced on Thursday, December 15th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, December 15th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

How do I buy shares of Cosmos Health?

Shares of COSM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Cosmos Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cosmos Health investors own include Meta Platforms (META), NVIDIA (NVDA), Adobe (ADBE), Broadcom (AVGO), CrowdStrike (CRWD), Arista Networks (ANET) and Builders FirstSource (BLDR).

Company Calendar

• Last Earnings: 8/18/2025
• Today: 9/06/2025
• Next Earnings (Estimated): 11/12/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: Wholesale
• Current Symbol: NASDAQ:COSM
• CIK: 1474167
• Web: www.cosmosholdingsinc.com
• Phone: (312) 536-3102
• Fax: N/A
• Employees: 100
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($1.03)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$16.18 million
• Net Margins: -27.90%
• Pretax Margin: -27.90%
• Return on Equity: -18.32%
• Return on Assets: -8.60%

Debt

• Debt-to-Equity Ratio: 0.08
• Current Ratio: 0.98
• Quick Ratio: 0.82

Sales & Book Value

• Annual Sales: $54.43 million
• Price / Sales: 0.36
• Cash Flow: $0.12 per share
• Price / Cash Flow: 5.59
• Book Value: $1.05 per share
• Price / Book: 0.62

Miscellaneous

• Outstanding Shares: 30,210,000
• Free Float: 22,630,000
• Market Cap: $19.61 million
• Optionable: Optionable
• Beta: 5.31